AU2013351947A1 - Method for evaluation of presence of or risk of colon tumors - Google Patents
Method for evaluation of presence of or risk of colon tumors Download PDFInfo
- Publication number
- AU2013351947A1 AU2013351947A1 AU2013351947A AU2013351947A AU2013351947A1 AU 2013351947 A1 AU2013351947 A1 AU 2013351947A1 AU 2013351947 A AU2013351947 A AU 2013351947A AU 2013351947 A AU2013351947 A AU 2013351947A AU 2013351947 A1 AU2013351947 A1 AU 2013351947A1
- Authority
- AU
- Australia
- Prior art keywords
- proteins
- subject
- adenoma
- amount
- polyp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 365
- 208000029742 colonic neoplasm Diseases 0.000 title abstract description 34
- 238000011156 evaluation Methods 0.000 title description 9
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 323
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 294
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 69
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 42
- 238000001514 detection method Methods 0.000 claims abstract description 39
- 238000011282 treatment Methods 0.000 claims abstract description 35
- 239000000090 biomarker Substances 0.000 claims description 195
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 149
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 110
- 239000000523 sample Substances 0.000 claims description 94
- 239000012472 biological sample Substances 0.000 claims description 86
- 208000037062 Polyps Diseases 0.000 claims description 85
- 206010009944 Colon cancer Diseases 0.000 claims description 83
- 238000004458 analytical method Methods 0.000 claims description 83
- 208000003200 Adenoma Diseases 0.000 claims description 69
- 208000014081 polyp of colon Diseases 0.000 claims description 69
- 206010001233 Adenoma benign Diseases 0.000 claims description 65
- -1 TPTI Proteins 0.000 claims description 63
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims description 62
- 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 claims description 59
- 101000914324 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 5 Proteins 0.000 claims description 58
- 101001091538 Homo sapiens Pyruvate kinase PKM Proteins 0.000 claims description 58
- 102100034911 Pyruvate kinase PKM Human genes 0.000 claims description 58
- 102100025144 Serine protease inhibitor Kazal-type 1 Human genes 0.000 claims description 49
- 238000012360 testing method Methods 0.000 claims description 48
- 210000004027 cell Anatomy 0.000 claims description 45
- 201000010989 colorectal carcinoma Diseases 0.000 claims description 41
- 238000004949 mass spectrometry Methods 0.000 claims description 40
- 238000002052 colonoscopy Methods 0.000 claims description 37
- 102100031298 Proteasome activator complex subunit 3 Human genes 0.000 claims description 36
- 101000705766 Homo sapiens Proteasome activator complex subunit 3 Proteins 0.000 claims description 35
- 229920001184 polypeptide Polymers 0.000 claims description 34
- 102100034283 Annexin A5 Human genes 0.000 claims description 33
- 101000780122 Homo sapiens Annexin A5 Proteins 0.000 claims description 33
- 102100028896 Heterogeneous nuclear ribonucleoprotein Q Human genes 0.000 claims description 32
- 102100023972 Keratin, type II cytoskeletal 8 Human genes 0.000 claims description 32
- 102100032420 Protein S100-A9 Human genes 0.000 claims description 32
- 102100023542 Ribosome-binding protein 1 Human genes 0.000 claims description 32
- 102100039037 Vascular endothelial growth factor A Human genes 0.000 claims description 32
- 238000009739 binding Methods 0.000 claims description 32
- 102100020925 Adenosylhomocysteinase Human genes 0.000 claims description 31
- 102100034618 Annexin A3 Human genes 0.000 claims description 31
- 102100034612 Annexin A4 Human genes 0.000 claims description 31
- 101000716952 Homo sapiens Adenosylhomocysteinase Proteins 0.000 claims description 31
- 101000924454 Homo sapiens Annexin A3 Proteins 0.000 claims description 31
- 101000924461 Homo sapiens Annexin A4 Proteins 0.000 claims description 31
- 101000975496 Homo sapiens Keratin, type II cytoskeletal 8 Proteins 0.000 claims description 31
- 101000760817 Homo sapiens Macrophage-capping protein Proteins 0.000 claims description 31
- 101000683584 Homo sapiens Ribosome-binding protein 1 Proteins 0.000 claims description 31
- 101000808011 Homo sapiens Vascular endothelial growth factor A Proteins 0.000 claims description 31
- 102100024573 Macrophage-capping protein Human genes 0.000 claims description 31
- 102100034925 P-selectin glycoprotein ligand 1 Human genes 0.000 claims description 31
- 230000027455 binding Effects 0.000 claims description 31
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 claims description 31
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 30
- INZOTETZQBPBCE-NYLDSJSYSA-N 3-sialyl lewis Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]([C@H](O)CO)[C@@H]([C@@H](NC(C)=O)C=O)O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O1 INZOTETZQBPBCE-NYLDSJSYSA-N 0.000 claims description 30
- 102100027271 40S ribosomal protein SA Human genes 0.000 claims description 30
- 102100036589 Glycine-tRNA ligase Human genes 0.000 claims description 30
- 108010052495 Calgranulin B Proteins 0.000 claims description 29
- 102100034000 Heterogeneous nuclear ribonucleoprotein F Human genes 0.000 claims description 29
- 101000694288 Homo sapiens 40S ribosomal protein SA Proteins 0.000 claims description 29
- 101000839069 Homo sapiens Heterogeneous nuclear ribonucleoprotein Q Proteins 0.000 claims description 29
- 101001057699 Homo sapiens Inorganic pyrophosphatase Proteins 0.000 claims description 29
- 101000873418 Homo sapiens P-selectin glycoprotein ligand 1 Proteins 0.000 claims description 29
- 102100023252 Nucleoside diphosphate kinase A Human genes 0.000 claims description 29
- 108010035766 P-Selectin Proteins 0.000 claims description 29
- 102100023472 P-selectin Human genes 0.000 claims description 29
- 230000035945 sensitivity Effects 0.000 claims description 29
- OXXJZDJLYSMGIQ-ZRDIBKRKSA-N 8-[2-[(e)-3-hydroxypent-1-enyl]-5-oxocyclopent-3-en-1-yl]octanoic acid Chemical compound CCC(O)\C=C\C1C=CC(=O)C1CCCCCCCC(O)=O OXXJZDJLYSMGIQ-ZRDIBKRKSA-N 0.000 claims description 28
- 101001017544 Homo sapiens Heterogeneous nuclear ribonucleoprotein F Proteins 0.000 claims description 28
- 101000979629 Homo sapiens Nucleoside diphosphate kinase A Proteins 0.000 claims description 28
- 102100027050 Inorganic pyrophosphatase Human genes 0.000 claims description 28
- 108010064209 Phosphoribosylglycinamide formyltransferase Proteins 0.000 claims description 28
- 241000252141 Semionotiformes Species 0.000 claims description 28
- 201000011510 cancer Diseases 0.000 claims description 28
- 238000003745 diagnosis Methods 0.000 claims description 28
- 108010034343 phosphoribosylamine-glycine ligase Proteins 0.000 claims description 28
- 101150096895 HSPB1 gene Proteins 0.000 claims description 27
- 102100039165 Heat shock protein beta-1 Human genes 0.000 claims description 27
- 108010093811 Kazal Pancreatic Trypsin Inhibitor Proteins 0.000 claims description 27
- 208000004804 Adenomatous Polyps Diseases 0.000 claims description 25
- 102100035875 C-C chemokine receptor type 5 Human genes 0.000 claims description 25
- 101710149870 C-C chemokine receptor type 5 Proteins 0.000 claims description 25
- 230000007935 neutral effect Effects 0.000 claims description 25
- 102100040523 Plasma alpha-L-fucosidase Human genes 0.000 claims description 22
- 206010048832 Colon adenoma Diseases 0.000 claims description 21
- 210000002381 plasma Anatomy 0.000 claims description 20
- 210000004369 blood Anatomy 0.000 claims description 18
- 239000008280 blood Substances 0.000 claims description 18
- 230000001900 immune effect Effects 0.000 claims description 18
- 238000004393 prognosis Methods 0.000 claims description 18
- 210000002966 serum Anatomy 0.000 claims description 17
- 210000001519 tissue Anatomy 0.000 claims description 17
- 238000000684 flow cytometry Methods 0.000 claims description 14
- 208000024891 symptom Diseases 0.000 claims description 14
- 102100029887 Translationally-controlled tumor protein Human genes 0.000 claims description 13
- 210000001072 colon Anatomy 0.000 claims description 13
- 102000004190 Enzymes Human genes 0.000 claims description 12
- 108090000790 Enzymes Proteins 0.000 claims description 12
- 102000007079 Peptide Fragments Human genes 0.000 claims description 12
- 108010033276 Peptide Fragments Proteins 0.000 claims description 12
- 238000001356 surgical procedure Methods 0.000 claims description 12
- 206010058314 Dysplasia Diseases 0.000 claims description 11
- 238000012544 monitoring process Methods 0.000 claims description 11
- 238000012549 training Methods 0.000 claims description 11
- 208000019399 Colonic disease Diseases 0.000 claims description 10
- 101000653679 Homo sapiens Translationally-controlled tumor protein Proteins 0.000 claims description 10
- 238000003384 imaging method Methods 0.000 claims description 10
- 102100025064 Cellular tumor antigen p53 Human genes 0.000 claims description 9
- 102100033055 Transketolase Human genes 0.000 claims description 9
- 238000002965 ELISA Methods 0.000 claims description 8
- 101100013466 Lablab purpureus FRIL gene Proteins 0.000 claims description 8
- 239000002207 metabolite Substances 0.000 claims description 8
- 102100023877 E3 ubiquitin-protein ligase RBX1 Human genes 0.000 claims description 7
- 101710095156 E3 ubiquitin-protein ligase RBX1 Proteins 0.000 claims description 7
- 102100040896 Growth/differentiation factor 15 Human genes 0.000 claims description 7
- 102100036427 Spondin-2 Human genes 0.000 claims description 7
- 102100036471 Tropomyosin beta chain Human genes 0.000 claims description 7
- 102100032807 Tumor necrosis factor-inducible gene 6 protein Human genes 0.000 claims description 7
- 238000011161 development Methods 0.000 claims description 7
- 230000002255 enzymatic effect Effects 0.000 claims description 7
- 230000036210 malignancy Effects 0.000 claims description 7
- 101150016799 ADT2 gene Proteins 0.000 claims description 6
- 101000737574 Homo sapiens Complement factor H Proteins 0.000 claims description 6
- 101001031607 Homo sapiens Four and a half LIM domains protein 1 Proteins 0.000 claims description 6
- 101000893549 Homo sapiens Growth/differentiation factor 15 Proteins 0.000 claims description 6
- 101000642258 Homo sapiens Spondin-2 Proteins 0.000 claims description 6
- 101000851892 Homo sapiens Tropomyosin beta chain Proteins 0.000 claims description 6
- 101000847156 Homo sapiens Tumor necrosis factor-inducible gene 6 protein Proteins 0.000 claims description 6
- 102100028489 Phosphatidylethanolamine-binding protein 1 Human genes 0.000 claims description 6
- 101710178916 RING-box protein 1 Proteins 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 6
- 230000003902 lesion Effects 0.000 claims description 6
- RLAWWYSOJDYHDC-BZSNNMDCSA-N lisinopril Chemical compound C([C@H](N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(O)=O)C(O)=O)CC1=CC=CC=C1 RLAWWYSOJDYHDC-BZSNNMDCSA-N 0.000 claims description 6
- 102100022277 Fructose-bisphosphate aldolase A Human genes 0.000 claims description 5
- 101000929429 Homo sapiens Discoidin domain-containing receptor 2 Proteins 0.000 claims description 5
- 101000987493 Homo sapiens Phosphatidylethanolamine-binding protein 1 Proteins 0.000 claims description 5
- 101000692878 Homo sapiens Regulator of MON1-CCZ1 complex Proteins 0.000 claims description 5
- 101000800463 Homo sapiens Transketolase Proteins 0.000 claims description 5
- 102100022745 Laminin subunit alpha-2 Human genes 0.000 claims description 5
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 5
- 239000000470 constituent Substances 0.000 claims description 5
- 239000007850 fluorescent dye Substances 0.000 claims description 5
- 239000000499 gel Substances 0.000 claims description 5
- 238000003119 immunoblot Methods 0.000 claims description 5
- 238000004611 spectroscopical analysis Methods 0.000 claims description 5
- 102100022524 Alpha-1-antichymotrypsin Human genes 0.000 claims description 4
- 101000678026 Homo sapiens Alpha-1-antichymotrypsin Proteins 0.000 claims description 4
- 101000755879 Homo sapiens Fructose-bisphosphate aldolase A Proteins 0.000 claims description 4
- 101000972491 Homo sapiens Laminin subunit alpha-2 Proteins 0.000 claims description 4
- 102100039364 Metalloproteinase inhibitor 1 Human genes 0.000 claims description 4
- 102100038990 Multiple epidermal growth factor-like domains protein 8 Human genes 0.000 claims description 4
- 101000898020 Synechocystis sp. (strain PCC 6803 / Kazusa) Homogentisate phytyltransferase Proteins 0.000 claims description 4
- 101710111280 Vacuolar protein sorting-associated protein VTA1 homolog Proteins 0.000 claims description 4
- 208000011769 benign colon neoplasm Diseases 0.000 claims description 4
- 210000001185 bone marrow Anatomy 0.000 claims description 4
- 210000003467 cheek Anatomy 0.000 claims description 4
- 210000000416 exudates and transudate Anatomy 0.000 claims description 4
- 238000012744 immunostaining Methods 0.000 claims description 4
- 210000004880 lymph fluid Anatomy 0.000 claims description 4
- 210000003296 saliva Anatomy 0.000 claims description 4
- 210000002700 urine Anatomy 0.000 claims description 4
- 238000001262 western blot Methods 0.000 claims description 4
- 102100034540 Adenomatous polyposis coli protein Human genes 0.000 claims description 3
- 102100022712 Alpha-1-antitrypsin Human genes 0.000 claims description 3
- 102100033407 Alpha-amylase 2B Human genes 0.000 claims description 3
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims description 3
- 102100030802 Beta-2-glycoprotein 1 Human genes 0.000 claims description 3
- 102100033620 Calponin-1 Human genes 0.000 claims description 3
- 102100029968 Calreticulin Human genes 0.000 claims description 3
- 101100235075 Cicer arietinum leg3 gene Proteins 0.000 claims description 3
- 102100026846 Cytidine deaminase Human genes 0.000 claims description 3
- 108010031325 Cytidine deaminase Proteins 0.000 claims description 3
- 102100021389 DNA replication licensing factor MCM4 Human genes 0.000 claims description 3
- 102100025012 Dipeptidyl peptidase 4 Human genes 0.000 claims description 3
- 102100031334 Elongation factor 2 Human genes 0.000 claims description 3
- 102100024524 F-box only protein 4 Human genes 0.000 claims description 3
- 102100038514 FERM domain-containing protein 3 Human genes 0.000 claims description 3
- 241000282326 Felis catus Species 0.000 claims description 3
- 102100026561 Filamin-A Human genes 0.000 claims description 3
- 102100021866 Hepatocyte growth factor Human genes 0.000 claims description 3
- 101001055314 Homo sapiens Immunoglobulin heavy constant alpha 2 Proteins 0.000 claims description 3
- 101000669513 Homo sapiens Metalloproteinase inhibitor 1 Proteins 0.000 claims description 3
- 102100039238 Hyaluronan-binding protein 2 Human genes 0.000 claims description 3
- 102100026216 Immunoglobulin heavy constant alpha 2 Human genes 0.000 claims description 3
- 102100037852 Insulin-like growth factor I Human genes 0.000 claims description 3
- 102100026879 Interleukin-2 receptor subunit beta Human genes 0.000 claims description 3
- 102000004890 Interleukin-8 Human genes 0.000 claims description 3
- 108090001007 Interleukin-8 Proteins 0.000 claims description 3
- 108010002335 Interleukin-9 Proteins 0.000 claims description 3
- 102100029997 Intraflagellar transport protein 74 homolog Human genes 0.000 claims description 3
- 102100030417 Matrilysin Human genes 0.000 claims description 3
- 102100030412 Matrix metalloproteinase-9 Human genes 0.000 claims description 3
- 101000573172 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) Nucleoside diphosphate kinase Proteins 0.000 claims description 3
- 102100031829 Myosin light polypeptide 6 Human genes 0.000 claims description 3
- 102100031787 Myosin regulatory light polypeptide 9 Human genes 0.000 claims description 3
- 102100024761 Neutrophil defensin 3 Human genes 0.000 claims description 3
- 102100020749 Pantetheinase Human genes 0.000 claims description 3
- 102100029139 Peroxiredoxin-1 Human genes 0.000 claims description 3
- 102100037061 Protein disulfide-isomerase A6 Human genes 0.000 claims description 3
- 102100037787 Protein-tyrosine kinase 2-beta Human genes 0.000 claims description 3
- 102100038517 Pyridoxal kinase Human genes 0.000 claims description 3
- 102100037889 Regenerating islet-derived protein 4 Human genes 0.000 claims description 3
- 102100027611 Rho-related GTP-binding protein RhoB Human genes 0.000 claims description 3
- 102100027610 Rho-related GTP-binding protein RhoC Human genes 0.000 claims description 3
- 108060006706 SRC Proteins 0.000 claims description 3
- 101710083332 Serum amyloid A-2 protein Proteins 0.000 claims description 3
- 102100032007 Serum amyloid A-2 protein Human genes 0.000 claims description 3
- 102100038081 Signal transducer CD24 Human genes 0.000 claims description 3
- 102100021816 Splicing factor 3B subunit 3 Human genes 0.000 claims description 3
- 102100022760 Stress-70 protein, mitochondrial Human genes 0.000 claims description 3
- 102100022387 Transforming protein RhoA Human genes 0.000 claims description 3
- 101710157927 Translationally-controlled tumor protein Proteins 0.000 claims description 3
- 102100026222 Transmembrane gamma-carboxyglutamic acid protein 4 Human genes 0.000 claims description 3
- 102100029640 UDP-glucose 6-dehydrogenase Human genes 0.000 claims description 3
- WZXXZHONLFRKGG-UHFFFAOYSA-N 2,3,4,5-tetrachlorothiophene Chemical compound ClC=1SC(Cl)=C(Cl)C=1Cl WZXXZHONLFRKGG-UHFFFAOYSA-N 0.000 claims description 2
- VACHUYIREGFMSP-UHFFFAOYSA-N 9,10-dihydroxyoctadecanoic acid Chemical compound CCCCCCCCC(O)C(O)CCCCCCCC(O)=O VACHUYIREGFMSP-UHFFFAOYSA-N 0.000 claims description 2
- 102100020970 ATP-binding cassette sub-family D member 2 Human genes 0.000 claims description 2
- 102100040006 Annexin A1 Human genes 0.000 claims description 2
- 102100033715 Apolipoprotein A-I Human genes 0.000 claims description 2
- 101100339431 Arabidopsis thaliana HMGB2 gene Proteins 0.000 claims description 2
- 101100243447 Arabidopsis thaliana PER53 gene Proteins 0.000 claims description 2
- 102100025222 CD63 antigen Human genes 0.000 claims description 2
- 101100108866 Callithrix jacchus AGT gene Proteins 0.000 claims description 2
- 101100219384 Chlamydomonas reinhardtii CAH2 gene Proteins 0.000 claims description 2
- 101800000414 Corticotropin Proteins 0.000 claims description 2
- 239000000055 Corticotropin-Releasing Hormone Substances 0.000 claims description 2
- VXPARNCTMSWSHF-DNVSUFBTSA-N Dihydrosanguinarine Natural products O=C1[C@H](C(C)=C)C[C@]2(CO)[C@@H](C)[C@H](O)CCC2=C1 VXPARNCTMSWSHF-DNVSUFBTSA-N 0.000 claims description 2
- 102100030943 Glutathione S-transferase P Human genes 0.000 claims description 2
- 108700010013 HMGB1 Proteins 0.000 claims description 2
- 101150021904 HMGB1 gene Proteins 0.000 claims description 2
- 102100026973 Heat shock protein 75 kDa, mitochondrial Human genes 0.000 claims description 2
- 102100037907 High mobility group protein B1 Human genes 0.000 claims description 2
- 101000783774 Homo sapiens ATP-binding cassette sub-family D member 2 Proteins 0.000 claims description 2
- 101000924577 Homo sapiens Adenomatous polyposis coli protein Proteins 0.000 claims description 2
- 101000823116 Homo sapiens Alpha-1-antitrypsin Proteins 0.000 claims description 2
- 101000732641 Homo sapiens Alpha-amylase 2B Proteins 0.000 claims description 2
- 101000959738 Homo sapiens Annexin A1 Proteins 0.000 claims description 2
- 101000733802 Homo sapiens Apolipoprotein A-I Proteins 0.000 claims description 2
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims description 2
- 101000793425 Homo sapiens Beta-2-glycoprotein 1 Proteins 0.000 claims description 2
- 101000934368 Homo sapiens CD63 antigen Proteins 0.000 claims description 2
- 101000945318 Homo sapiens Calponin-1 Proteins 0.000 claims description 2
- 101000793651 Homo sapiens Calreticulin Proteins 0.000 claims description 2
- 101000615280 Homo sapiens DNA replication licensing factor MCM4 Proteins 0.000 claims description 2
- 101000908391 Homo sapiens Dipeptidyl peptidase 4 Proteins 0.000 claims description 2
- 101001052775 Homo sapiens F-box only protein 4 Proteins 0.000 claims description 2
- 101001030545 Homo sapiens FERM domain-containing protein 3 Proteins 0.000 claims description 2
- 101000913549 Homo sapiens Filamin-A Proteins 0.000 claims description 2
- 101001010139 Homo sapiens Glutathione S-transferase P Proteins 0.000 claims description 2
- 101000898034 Homo sapiens Hepatocyte growth factor Proteins 0.000 claims description 2
- 101001035951 Homo sapiens Hyaluronan-binding protein 2 Proteins 0.000 claims description 2
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 claims description 2
- 101001055145 Homo sapiens Interleukin-2 receptor subunit beta Proteins 0.000 claims description 2
- 101001076408 Homo sapiens Interleukin-6 Proteins 0.000 claims description 2
- 101001010835 Homo sapiens Intraflagellar transport protein 74 homolog Proteins 0.000 claims description 2
- 101001003581 Homo sapiens Lamin-B1 Proteins 0.000 claims description 2
- 101000990912 Homo sapiens Matrilysin Proteins 0.000 claims description 2
- 101000990902 Homo sapiens Matrix metalloproteinase-9 Proteins 0.000 claims description 2
- 101001128460 Homo sapiens Myosin light polypeptide 6 Proteins 0.000 claims description 2
- 101001128456 Homo sapiens Myosin regulatory light polypeptide 9 Proteins 0.000 claims description 2
- 101000830386 Homo sapiens Neutrophil defensin 3 Proteins 0.000 claims description 2
- 101000603202 Homo sapiens Nicotinamide N-methyltransferase Proteins 0.000 claims description 2
- 101000854777 Homo sapiens Pantetheinase Proteins 0.000 claims description 2
- 101001124867 Homo sapiens Peroxiredoxin-1 Proteins 0.000 claims description 2
- 101001098802 Homo sapiens Protein disulfide-isomerase A3 Proteins 0.000 claims description 2
- 101001098769 Homo sapiens Protein disulfide-isomerase A6 Proteins 0.000 claims description 2
- 101000878540 Homo sapiens Protein-tyrosine kinase 2-beta Proteins 0.000 claims description 2
- 101001099586 Homo sapiens Pyridoxal kinase Proteins 0.000 claims description 2
- 101000743264 Homo sapiens RNA-binding protein 6 Proteins 0.000 claims description 2
- 101001096074 Homo sapiens Regenerating islet-derived protein 4 Proteins 0.000 claims description 2
- 101000581118 Homo sapiens Rho-related GTP-binding protein RhoC Proteins 0.000 claims description 2
- 101000654764 Homo sapiens Secretagogin Proteins 0.000 claims description 2
- 101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 claims description 2
- 101000868152 Homo sapiens Son of sevenless homolog 1 Proteins 0.000 claims description 2
- 101000616172 Homo sapiens Splicing factor 3B subunit 3 Proteins 0.000 claims description 2
- 101000764634 Homo sapiens Transmembrane gamma-carboxyglutamic acid protein 4 Proteins 0.000 claims description 2
- 101000939529 Homo sapiens UDP-glucose 6-dehydrogenase Proteins 0.000 claims description 2
- 108091058560 IL8 Proteins 0.000 claims description 2
- 102100026517 Lamin-B1 Human genes 0.000 claims description 2
- 108060004872 MIF Proteins 0.000 claims description 2
- 102100028123 Macrophage colony-stimulating factor 1 Human genes 0.000 claims description 2
- 102100039143 Magnesium transporter MRS2 homolog, mitochondrial Human genes 0.000 claims description 2
- 101100078144 Mus musculus Msrb1 gene Proteins 0.000 claims description 2
- 101100477261 Mus musculus Selplg gene Proteins 0.000 claims description 2
- 102100029494 Neutrophil defensin 1 Human genes 0.000 claims description 2
- 102100038951 Nicotinamide N-methyltransferase Human genes 0.000 claims description 2
- 102100037097 Protein disulfide-isomerase A3 Human genes 0.000 claims description 2
- 102100033810 RAC-alpha serine/threonine-protein kinase Human genes 0.000 claims description 2
- 101150111584 RHOA gene Proteins 0.000 claims description 2
- 101150054980 Rhob gene Proteins 0.000 claims description 2
- 102000000341 S-Phase Kinase-Associated Proteins Human genes 0.000 claims description 2
- 108010055623 S-Phase Kinase-Associated Proteins Proteins 0.000 claims description 2
- 102000001332 SRC Human genes 0.000 claims description 2
- 101150005863 SYNCRIP gene Proteins 0.000 claims description 2
- 101100478275 Schizosaccharomyces pombe (strain 972 / ATCC 24843) spt8 gene Proteins 0.000 claims description 2
- 102100032621 Secretagogin Human genes 0.000 claims description 2
- 102100026715 Serine/threonine-protein kinase STK11 Human genes 0.000 claims description 2
- 101150080074 TP53 gene Proteins 0.000 claims description 2
- 101710175870 Translationally-controlled tumor protein homolog Proteins 0.000 claims description 2
- 101100290417 Zea mays ROA1 gene Proteins 0.000 claims description 2
- 101100290418 Zea mays ROA2 gene Proteins 0.000 claims description 2
- 101150026213 atpB gene Proteins 0.000 claims description 2
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 claims description 2
- 229960000258 corticotropin Drugs 0.000 claims description 2
- HDRXZJPWHTXQRI-BHDTVMLSSA-N diltiazem hydrochloride Chemical compound [Cl-].C1=CC(OC)=CC=C1[C@H]1[C@@H](OC(C)=O)C(=O)N(CC[NH+](C)C)C2=CC=CC=C2S1 HDRXZJPWHTXQRI-BHDTVMLSSA-N 0.000 claims description 2
- 229940090124 dipeptidyl peptidase 4 (dpp-4) inhibitors for blood glucose lowering Drugs 0.000 claims description 2
- 108010017007 glucose-regulated proteins Proteins 0.000 claims description 2
- NJHLGKJQFKUSEA-UHFFFAOYSA-N n-[2-(4-hydroxyphenyl)ethyl]-n-methylnitrous amide Chemical compound O=NN(C)CCC1=CC=C(O)C=C1 NJHLGKJQFKUSEA-UHFFFAOYSA-N 0.000 claims description 2
- 230000002797 proteolythic effect Effects 0.000 claims description 2
- 230000002285 radioactive effect Effects 0.000 claims description 2
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 claims 20
- 101000893745 Homo sapiens Plasma alpha-L-fucosidase Proteins 0.000 claims 20
- ZBZXYUYUUDZCNB-UHFFFAOYSA-N N-cyclohexa-1,3-dien-1-yl-N-phenyl-4-[4-(N-[4-[4-(N-[4-[4-(N-phenylanilino)phenyl]phenyl]anilino)phenyl]phenyl]anilino)phenyl]aniline Chemical compound C1=CCCC(N(C=2C=CC=CC=2)C=2C=CC(=CC=2)C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C=CC(=CC=2)C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C=CC(=CC=2)C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 ZBZXYUYUUDZCNB-UHFFFAOYSA-N 0.000 claims 9
- 230000002788 anti-peptide Effects 0.000 claims 6
- 230000009257 reactivity Effects 0.000 claims 4
- 230000000951 immunodiffusion Effects 0.000 claims 3
- 238000000760 immunoelectrophoresis Methods 0.000 claims 3
- 238000001114 immunoprecipitation Methods 0.000 claims 3
- 238000003127 radioimmunoassay Methods 0.000 claims 3
- 108091011896 CSF1 Proteins 0.000 claims 1
- 102100035432 Complement factor H Human genes 0.000 claims 1
- 101000918983 Homo sapiens Neutrophil defensin 1 Proteins 0.000 claims 1
- 101000779418 Homo sapiens RAC-alpha serine/threonine-protein kinase Proteins 0.000 claims 1
- 101000628562 Homo sapiens Serine/threonine-protein kinase STK11 Proteins 0.000 claims 1
- 101000659879 Homo sapiens Thrombospondin-1 Proteins 0.000 claims 1
- 102000000585 Interleukin-9 Human genes 0.000 claims 1
- 108010011536 PTEN Phosphohydrolase Proteins 0.000 claims 1
- 102000014160 PTEN Phosphohydrolase Human genes 0.000 claims 1
- 102100036034 Thrombospondin-1 Human genes 0.000 claims 1
- 101710204707 Transforming growth factor-beta receptor-associated protein 1 Proteins 0.000 claims 1
- 101100152546 Uromyces fabae TBB1 gene Proteins 0.000 claims 1
- 239000012736 aqueous medium Substances 0.000 claims 1
- 238000000326 densiometry Methods 0.000 claims 1
- 238000000695 excitation spectrum Methods 0.000 claims 1
- 201000010099 disease Diseases 0.000 abstract description 63
- 230000004044 response Effects 0.000 abstract description 34
- 238000010606 normalization Methods 0.000 abstract description 21
- 235000018102 proteins Nutrition 0.000 description 226
- 230000014509 gene expression Effects 0.000 description 55
- 239000002243 precursor Substances 0.000 description 54
- 150000002500 ions Chemical class 0.000 description 42
- 239000012634 fragment Substances 0.000 description 41
- 238000003556 assay Methods 0.000 description 34
- 239000000427 antigen Substances 0.000 description 29
- 238000004422 calculation algorithm Methods 0.000 description 29
- 108091007433 antigens Proteins 0.000 description 28
- 102000036639 antigens Human genes 0.000 description 28
- 108020004414 DNA Proteins 0.000 description 25
- 238000005259 measurement Methods 0.000 description 22
- 238000002493 microarray Methods 0.000 description 22
- 238000012545 processing Methods 0.000 description 21
- 238000000018 DNA microarray Methods 0.000 description 20
- 150000001413 amino acids Chemical group 0.000 description 20
- 239000003550 marker Substances 0.000 description 19
- 238000007726 management method Methods 0.000 description 18
- 102000039446 nucleic acids Human genes 0.000 description 17
- 150000007523 nucleic acids Chemical class 0.000 description 17
- 238000003860 storage Methods 0.000 description 17
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 16
- 239000000203 mixture Substances 0.000 description 16
- 230000008569 process Effects 0.000 description 16
- 230000000875 corresponding effect Effects 0.000 description 15
- 235000001014 amino acid Nutrition 0.000 description 14
- 108020004999 messenger RNA Proteins 0.000 description 14
- 108090000631 Trypsin Proteins 0.000 description 13
- 102000004142 Trypsin Human genes 0.000 description 13
- 238000002405 diagnostic procedure Methods 0.000 description 13
- 108020004707 nucleic acids Proteins 0.000 description 13
- 239000011230 binding agent Substances 0.000 description 12
- 238000003018 immunoassay Methods 0.000 description 12
- 239000013610 patient sample Substances 0.000 description 12
- 230000007704 transition Effects 0.000 description 12
- 239000012588 trypsin Substances 0.000 description 12
- 102100031196 Choriogonadotropin subunit beta 3 Human genes 0.000 description 11
- 239000003153 chemical reaction reagent Substances 0.000 description 11
- 238000002790 cross-validation Methods 0.000 description 11
- 229940088598 enzyme Drugs 0.000 description 11
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 10
- 238000011002 quantification Methods 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 238000013459 approach Methods 0.000 description 9
- 239000000975 dye Substances 0.000 description 9
- 230000036961 partial effect Effects 0.000 description 9
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 239000012071 phase Substances 0.000 description 8
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 7
- 102000001626 Kazal Pancreatic Trypsin Inhibitor Human genes 0.000 description 7
- 241000124008 Mammalia Species 0.000 description 7
- 102000035195 Peptidases Human genes 0.000 description 7
- 108091005804 Peptidases Proteins 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 230000029087 digestion Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 230000004048 modification Effects 0.000 description 7
- 238000012986 modification Methods 0.000 description 7
- 238000002552 multiple reaction monitoring Methods 0.000 description 7
- 239000002773 nucleotide Substances 0.000 description 7
- 125000003729 nucleotide group Chemical group 0.000 description 7
- 230000002093 peripheral effect Effects 0.000 description 7
- 238000000926 separation method Methods 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 238000010200 validation analysis Methods 0.000 description 7
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 239000002299 complementary DNA Substances 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 6
- 239000013615 primer Substances 0.000 description 6
- 238000003757 reverse transcription PCR Methods 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 238000012706 support-vector machine Methods 0.000 description 6
- 102000004506 Blood Proteins Human genes 0.000 description 5
- 108010017384 Blood Proteins Proteins 0.000 description 5
- 201000009030 Carcinoma Diseases 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 108010031374 Tissue Inhibitor of Metalloproteinase-1 Proteins 0.000 description 5
- 102000005353 Tissue Inhibitor of Metalloproteinase-1 Human genes 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 239000012491 analyte Substances 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 238000004891 communication Methods 0.000 description 5
- 238000004590 computer program Methods 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 229920002521 macromolecule Polymers 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 230000026731 phosphorylation Effects 0.000 description 5
- 238000006366 phosphorylation reaction Methods 0.000 description 5
- 102000040430 polynucleotide Human genes 0.000 description 5
- 108091033319 polynucleotide Proteins 0.000 description 5
- 239000002157 polynucleotide Substances 0.000 description 5
- 230000017854 proteolysis Effects 0.000 description 5
- 239000013643 reference control Substances 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 102100022299 All trans-polyprenyl-diphosphate synthase PDSS1 Human genes 0.000 description 4
- 101710093939 All trans-polyprenyl-diphosphate synthase PDSS1 Proteins 0.000 description 4
- 102100031780 Endonuclease Human genes 0.000 description 4
- 102100038651 Four and a half LIM domains protein 1 Human genes 0.000 description 4
- 108091005461 Nucleic proteins Proteins 0.000 description 4
- 108091093037 Peptide nucleic acid Proteins 0.000 description 4
- 108010006785 Taq Polymerase Proteins 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 125000000539 amino acid group Chemical group 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- 238000013145 classification model Methods 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 230000007717 exclusion Effects 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 230000010354 integration Effects 0.000 description 4
- 239000003446 ligand Substances 0.000 description 4
- 230000000670 limiting effect Effects 0.000 description 4
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 4
- 239000012160 loading buffer Substances 0.000 description 4
- 230000003211 malignant effect Effects 0.000 description 4
- 230000001575 pathological effect Effects 0.000 description 4
- 102000054765 polymorphisms of proteins Human genes 0.000 description 4
- 230000004481 post-translational protein modification Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 235000019833 protease Nutrition 0.000 description 4
- 230000009870 specific binding Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 3
- 108091023037 Aptamer Proteins 0.000 description 3
- 108700039887 Essential Genes Proteins 0.000 description 3
- 238000004252 FT/ICR mass spectrometry Methods 0.000 description 3
- 108010044467 Isoenzymes Proteins 0.000 description 3
- 241000282842 Lama glama Species 0.000 description 3
- 108091092878 Microsatellite Proteins 0.000 description 3
- 101710163270 Nuclease Proteins 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 3
- 238000011529 RT qPCR Methods 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 108010071390 Serum Albumin Proteins 0.000 description 3
- 102000007562 Serum Albumin Human genes 0.000 description 3
- 230000003044 adaptive effect Effects 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 239000003463 adsorbent Substances 0.000 description 3
- 238000003491 array Methods 0.000 description 3
- 238000000668 atmospheric pressure chemical ionisation mass spectrometry Methods 0.000 description 3
- 238000001854 atmospheric pressure photoionisation mass spectrometry Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000000132 electrospray ionisation Methods 0.000 description 3
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 3
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- 230000007614 genetic variation Effects 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 230000013595 glycosylation Effects 0.000 description 3
- 238000006206 glycosylation reaction Methods 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 210000004408 hybridoma Anatomy 0.000 description 3
- 238000003364 immunohistochemistry Methods 0.000 description 3
- 238000000099 in vitro assay Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 238000005040 ion trap Methods 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 150000002632 lipids Chemical group 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 210000000496 pancreas Anatomy 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 208000022131 polyp of large intestine Diseases 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 235000019419 proteases Nutrition 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000004445 quantitative analysis Methods 0.000 description 3
- 238000003753 real-time PCR Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000010839 reverse transcription Methods 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 230000009897 systematic effect Effects 0.000 description 3
- 238000011277 treatment modality Methods 0.000 description 3
- 102100022900 Actin, cytoplasmic 1 Human genes 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 108091093088 Amplicon Proteins 0.000 description 2
- 102000000546 Apoferritins Human genes 0.000 description 2
- 108010002084 Apoferritins Proteins 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- 108090001008 Avidin Proteins 0.000 description 2
- 102100032752 C-reactive protein Human genes 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- OKTJSMMVPCPJKN-OUBTZVSYSA-N Carbon-13 Chemical compound [13C] OKTJSMMVPCPJKN-OUBTZVSYSA-N 0.000 description 2
- 101710116299 Choriogonadotropin subunit beta Proteins 0.000 description 2
- 108010047041 Complementarity Determining Regions Proteins 0.000 description 2
- 102100039195 Cullin-1 Human genes 0.000 description 2
- 238000012286 ELISA Assay Methods 0.000 description 2
- 102000005593 Endopeptidases Human genes 0.000 description 2
- 108010059378 Endopeptidases Proteins 0.000 description 2
- 241000283073 Equus caballus Species 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 108010004889 Heat-Shock Proteins Proteins 0.000 description 2
- 102000002812 Heat-Shock Proteins Human genes 0.000 description 2
- 108010019372 Heterogeneous-Nuclear Ribonucleoproteins Proteins 0.000 description 2
- 102000006479 Heterogeneous-Nuclear Ribonucleoproteins Human genes 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 108700005091 Immunoglobulin Genes Proteins 0.000 description 2
- 102100026871 Interleukin-9 Human genes 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 102000007474 Multiprotein Complexes Human genes 0.000 description 2
- 108010085220 Multiprotein Complexes Proteins 0.000 description 2
- 241001529936 Murinae Species 0.000 description 2
- 108010081372 NM23 Nucleoside Diphosphate Kinases Proteins 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 108010054395 P-selectin ligand protein Proteins 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 241000286209 Phasianidae Species 0.000 description 2
- 101710182890 Plasma alpha-L-fucosidase Proteins 0.000 description 2
- 108010029485 Protein Isoforms Proteins 0.000 description 2
- 102000001708 Protein Isoforms Human genes 0.000 description 2
- 102000013009 Pyruvate Kinase Human genes 0.000 description 2
- 108020005115 Pyruvate Kinase Proteins 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000021736 acetylation Effects 0.000 description 2
- 238000006640 acetylation reaction Methods 0.000 description 2
- 238000001042 affinity chromatography Methods 0.000 description 2
- 238000005349 anion exchange Methods 0.000 description 2
- 238000011394 anticancer treatment Methods 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 150000001720 carbohydrates Chemical group 0.000 description 2
- 239000013592 cell lysate Substances 0.000 description 2
- 235000013330 chicken meat Nutrition 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000007398 colorimetric assay Methods 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 238000013480 data collection Methods 0.000 description 2
- 238000013500 data storage Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000003795 desorption Methods 0.000 description 2
- 238000000688 desorption electrospray ionisation Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 238000010195 expression analysis Methods 0.000 description 2
- 230000002550 fecal effect Effects 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 238000002657 hormone replacement therapy Methods 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 229940072221 immunoglobulins Drugs 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 230000029226 lipidation Effects 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 230000011987 methylation Effects 0.000 description 2
- 238000007069 methylation reaction Methods 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000001581 pretranslational effect Effects 0.000 description 2
- 238000003498 protein array Methods 0.000 description 2
- 230000004850 protein–protein interaction Effects 0.000 description 2
- 230000006337 proteolytic cleavage Effects 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 238000012784 weak cation exchange Methods 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- 102100040685 14-3-3 protein zeta/delta Human genes 0.000 description 1
- 101710183121 14-3-3 protein zeta/delta Proteins 0.000 description 1
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 108050007366 40S ribosomal protein SA Proteins 0.000 description 1
- 102100038222 60 kDa heat shock protein, mitochondrial Human genes 0.000 description 1
- 101710154868 60 kDa heat shock protein, mitochondrial Proteins 0.000 description 1
- 101710148588 ADP,ATP carrier protein 2 Proteins 0.000 description 1
- 101710165307 ADP,ATP carrier protein 2, mitochondrial Proteins 0.000 description 1
- 102100026396 ADP/ATP translocase 2 Human genes 0.000 description 1
- 101710102718 ADP/ATP translocase 2 Proteins 0.000 description 1
- 102100022890 ATP synthase subunit beta, mitochondrial Human genes 0.000 description 1
- 101710134855 ATP synthase subunit beta, mitochondrial Proteins 0.000 description 1
- 101710119043 Actin, cytoplasmic 1 Proteins 0.000 description 1
- 102100022454 Actin, gamma-enteric smooth muscle Human genes 0.000 description 1
- 101710184997 Actin, gamma-enteric smooth muscle Proteins 0.000 description 1
- 101710196039 Actin-11 Proteins 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 108010038310 Adenomatous polyposis coli protein Proteins 0.000 description 1
- 102000005234 Adenosylhomocysteinase Human genes 0.000 description 1
- 108020002202 Adenosylhomocysteinase Proteins 0.000 description 1
- 101001015038 Albizia kalkora Kunitz-type trypsin inhibitor alpha chain Proteins 0.000 description 1
- 102100040069 Aldehyde dehydrogenase 1A1 Human genes 0.000 description 1
- 101710133479 Aldehyde dehydrogenase 1A1 Proteins 0.000 description 1
- 102100039074 Aldehyde dehydrogenase X, mitochondrial Human genes 0.000 description 1
- 101710150218 Aldehyde dehydrogenase X, mitochondrial Proteins 0.000 description 1
- 108010053754 Aldehyde reductase Proteins 0.000 description 1
- 102100027265 Aldo-keto reductase family 1 member B1 Human genes 0.000 description 1
- 101710082073 Alpha-amylase 2B Proteins 0.000 description 1
- 102100038910 Alpha-enolase Human genes 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 102000004881 Angiotensinogen Human genes 0.000 description 1
- 108090001067 Angiotensinogen Proteins 0.000 description 1
- 102000000412 Annexin Human genes 0.000 description 1
- 108050008874 Annexin Proteins 0.000 description 1
- 102000004120 Annexin A3 Human genes 0.000 description 1
- 108090000670 Annexin A3 Proteins 0.000 description 1
- 102000004148 Annexin A4 Human genes 0.000 description 1
- 108090000669 Annexin A4 Proteins 0.000 description 1
- 102000004121 Annexin A5 Human genes 0.000 description 1
- 108090000672 Annexin A5 Proteins 0.000 description 1
- 235000002198 Annona diversifolia Nutrition 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 108010059886 Apolipoprotein A-I Proteins 0.000 description 1
- 102000005666 Apolipoprotein A-I Human genes 0.000 description 1
- 102000011772 Apolipoprotein C-I Human genes 0.000 description 1
- 108010076807 Apolipoprotein C-I Proteins 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- 102100028820 Aspartate-tRNA ligase, cytoplasmic Human genes 0.000 description 1
- 101710156826 Aspartate-tRNA ligase, cytoplasmic Proteins 0.000 description 1
- 102000004580 Aspartic Acid Proteases Human genes 0.000 description 1
- 108010017640 Aspartic Acid Proteases Proteins 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 102100021568 B-cell scaffold protein with ankyrin repeats Human genes 0.000 description 1
- 101710135413 B-cell scaffold protein with ankyrin repeats Proteins 0.000 description 1
- 108050001413 B-lymphocyte antigen CD20 Proteins 0.000 description 1
- BXTVQNYQYUTQAZ-UHFFFAOYSA-N BNPS-skatole Chemical compound N=1C2=CC=CC=C2C(C)(Br)C=1SC1=CC=CC=C1[N+]([O-])=O BXTVQNYQYUTQAZ-UHFFFAOYSA-N 0.000 description 1
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- 101710180007 Beta-2-glycoprotein 1 Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108010074051 C-Reactive Protein Proteins 0.000 description 1
- 102100028672 C-type lectin domain family 4 member D Human genes 0.000 description 1
- 101710183451 C-type lectin domain family 4 member D Proteins 0.000 description 1
- 101700006667 CA1 Proteins 0.000 description 1
- 101100004286 Caenorhabditis elegans best-5 gene Proteins 0.000 description 1
- 102000005701 Calcium-Binding Proteins Human genes 0.000 description 1
- 108010045403 Calcium-Binding Proteins Proteins 0.000 description 1
- 101710092112 Calponin-1 Proteins 0.000 description 1
- 108090000549 Calreticulin Proteins 0.000 description 1
- 241000282826 Camelus Species 0.000 description 1
- 241000282828 Camelus bactrianus Species 0.000 description 1
- 241000282836 Camelus dromedarius Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 102100025518 Carbonic anhydrase 1 Human genes 0.000 description 1
- 102100024633 Carbonic anhydrase 2 Human genes 0.000 description 1
- 101710167917 Carbonic anhydrase 2 Proteins 0.000 description 1
- 102100025466 Carcinoembryonic antigen-related cell adhesion molecule 3 Human genes 0.000 description 1
- 101710190847 Carcinoembryonic antigen-related cell adhesion molecule 3 Proteins 0.000 description 1
- 101710190849 Carcinoembryonic antigen-related cell adhesion molecule 5 Proteins 0.000 description 1
- 102100025473 Carcinoembryonic antigen-related cell adhesion molecule 6 Human genes 0.000 description 1
- 101710190842 Carcinoembryonic antigen-related cell adhesion molecule 6 Proteins 0.000 description 1
- 108010067316 Catenins Proteins 0.000 description 1
- 102000016362 Catenins Human genes 0.000 description 1
- 102000003908 Cathepsin D Human genes 0.000 description 1
- 108090000258 Cathepsin D Proteins 0.000 description 1
- 108090000613 Cathepsin S Proteins 0.000 description 1
- 108010061117 Cathepsin Z Proteins 0.000 description 1
- 102000011937 Cathepsin Z Human genes 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 102000018704 Chitinase-3-Like Protein 1 Human genes 0.000 description 1
- 108010066813 Chitinase-3-Like Protein 1 Proteins 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 102000003780 Clusterin Human genes 0.000 description 1
- 108090000197 Clusterin Proteins 0.000 description 1
- 108010028780 Complement C3 Proteins 0.000 description 1
- 102000016918 Complement C3 Human genes 0.000 description 1
- 102000008929 Complement component C9 Human genes 0.000 description 1
- 108050000891 Complement component C9 Proteins 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 102100022785 Creatine kinase B-type Human genes 0.000 description 1
- 101710124411 Creatine kinase B-type Proteins 0.000 description 1
- 108010088874 Cullin 1 Proteins 0.000 description 1
- 108010005843 Cysteine Proteases Proteins 0.000 description 1
- 102000005927 Cysteine Proteases Human genes 0.000 description 1
- 102100031635 Cytoplasmic dynein 1 heavy chain 1 Human genes 0.000 description 1
- 101710204897 Cytoplasmic dynein 1 heavy chain 1 Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 102100040515 Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial Human genes 0.000 description 1
- 101710106485 Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial Proteins 0.000 description 1
- 102100036912 Desmin Human genes 0.000 description 1
- 108010044052 Desmin Proteins 0.000 description 1
- 238000009007 Diagnostic Kit Methods 0.000 description 1
- 102000011972 Dihydropyrimidinase-related protein 2 Human genes 0.000 description 1
- 235000017274 Diospyros sandwicensis Nutrition 0.000 description 1
- 108010067722 Dipeptidyl Peptidase 4 Proteins 0.000 description 1
- 102400000488 Dipeptidyl peptidase 4 soluble form Human genes 0.000 description 1
- 101800001665 Dipeptidyl peptidase 4 soluble form Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102100039328 Endoplasmin Human genes 0.000 description 1
- 102100025654 Endosome-associated-trafficking regulator 1 Human genes 0.000 description 1
- 101710090940 Endosome-associated-trafficking regulator 1 Proteins 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 102100022461 Eukaryotic initiation factor 4A-III Human genes 0.000 description 1
- 101710129990 Eukaryotic initiation factor 4A-III Proteins 0.000 description 1
- 102100020903 Ezrin Human genes 0.000 description 1
- 101710199772 F-box only protein 4 Proteins 0.000 description 1
- 101710196050 FERM domain-containing protein 3 Proteins 0.000 description 1
- 102400001064 Fibrinogen beta chain Human genes 0.000 description 1
- 101710170765 Fibrinogen beta chain Proteins 0.000 description 1
- 102100024783 Fibrinogen gamma chain Human genes 0.000 description 1
- 108060002900 Filamin Proteins 0.000 description 1
- 108010091824 Focal Adhesion Kinase 1 Proteins 0.000 description 1
- 102100037813 Focal adhesion kinase 1 Human genes 0.000 description 1
- 101710127220 Four and a half LIM domains protein 1 Proteins 0.000 description 1
- 101710123627 Fructose-bisphosphate aldolase A Proteins 0.000 description 1
- 102000005915 GABA Receptors Human genes 0.000 description 1
- 108010005551 GABA Receptors Proteins 0.000 description 1
- 102100030708 GTPase KRas Human genes 0.000 description 1
- 101710113436 GTPase KRas Proteins 0.000 description 1
- 108010001517 Galectin 3 Proteins 0.000 description 1
- 102100039558 Galectin-3 Human genes 0.000 description 1
- 201000003741 Gastrointestinal carcinoma Diseases 0.000 description 1
- 102000004878 Gelsolin Human genes 0.000 description 1
- 108090001064 Gelsolin Proteins 0.000 description 1
- 206010056740 Genital discharge Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 102000005720 Glutathione transferase Human genes 0.000 description 1
- 108010070675 Glutathione transferase Proteins 0.000 description 1
- 101710162684 Glyceraldehyde-3-phosphate dehydrogenase 3 Proteins 0.000 description 1
- 108010051724 Glycine-tRNA Ligase Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 101710194460 Growth/differentiation factor 15 Proteins 0.000 description 1
- 102100025255 Haptoglobin Human genes 0.000 description 1
- 108050005077 Haptoglobin Proteins 0.000 description 1
- 241000193159 Hathewaya histolytica Species 0.000 description 1
- 101710130649 Heat shock protein 75 kDa, mitochondrial Proteins 0.000 description 1
- 102100032510 Heat shock protein HSP 90-beta Human genes 0.000 description 1
- 101710163596 Heat shock protein HSP 90-beta Proteins 0.000 description 1
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 description 1
- 102100036284 Hepcidin Human genes 0.000 description 1
- 101710141316 Heterogeneous nuclear ribonucleoprotein F Proteins 0.000 description 1
- 101710141313 Heterogeneous nuclear ribonucleoprotein Q Proteins 0.000 description 1
- 102000018802 High Mobility Group Proteins Human genes 0.000 description 1
- 101710176246 High mobility group protein Proteins 0.000 description 1
- 108010088652 Histocompatibility Antigens Class I Proteins 0.000 description 1
- 102000008949 Histocompatibility Antigens Class I Human genes 0.000 description 1
- 101000756632 Homo sapiens Actin, cytoplasmic 1 Proteins 0.000 description 1
- 101000746063 Homo sapiens Cullin-1 Proteins 0.000 description 1
- 101001021253 Homo sapiens Hepcidin Proteins 0.000 description 1
- 101000979455 Homo sapiens Protein Niban 3 Proteins 0.000 description 1
- 101000891113 Homo sapiens T-cell acute lymphocytic leukemia protein 1 Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 101710163637 Hyaluronan-binding protein 2 Proteins 0.000 description 1
- 108010058683 Immobilized Proteins Proteins 0.000 description 1
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
- 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 1
- 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 1
- 108010009595 Inorganic Pyrophosphatase Proteins 0.000 description 1
- 102000009617 Inorganic Pyrophosphatase Human genes 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 108010028750 Integrin-Binding Sialoprotein Proteins 0.000 description 1
- 102000016921 Integrin-Binding Sialoprotein Human genes 0.000 description 1
- 101710154942 Interleukin-2 receptor subunit beta Proteins 0.000 description 1
- 101710098566 Intraflagellar transport protein 74 homolog Proteins 0.000 description 1
- 102100027612 Kallikrein-11 Human genes 0.000 description 1
- 102100033420 Keratin, type I cytoskeletal 19 Human genes 0.000 description 1
- 101710183399 Keratin, type I cytoskeletal 19 Proteins 0.000 description 1
- 101710194927 Keratin, type II cytoskeletal 8 Proteins 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- QEFRNWWLZKMPFJ-YGVKFDHGSA-N L-methionine S-oxide Chemical compound CS(=O)CC[C@H](N)C(O)=O QEFRNWWLZKMPFJ-YGVKFDHGSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 101710200519 Laminin subunit alpha-2 Proteins 0.000 description 1
- 108010028275 Leukocyte Elastase Proteins 0.000 description 1
- 241000863030 Lysobacter enzymogenes Species 0.000 description 1
- 108010048043 Macrophage Migration-Inhibitory Factors Proteins 0.000 description 1
- 101710127797 Macrophage colony-stimulating factor 1 Proteins 0.000 description 1
- 102100037791 Macrophage migration inhibitory factor Human genes 0.000 description 1
- 102000016453 Macrophage-capping proteins Human genes 0.000 description 1
- 108050006096 Macrophage-capping proteins Proteins 0.000 description 1
- 108090000855 Matrilysin Proteins 0.000 description 1
- 108010015302 Matrix metalloproteinase-9 Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 108050006599 Metalloproteinase inhibitor 1 Proteins 0.000 description 1
- 102100022465 Methanethiol oxidase Human genes 0.000 description 1
- 101710134383 Methanethiol oxidase Proteins 0.000 description 1
- 102100039560 Microtubule-associated protein RP/EB family member 1 Human genes 0.000 description 1
- 101710099411 Microtubule-associated protein RP/EB family member 1 Proteins 0.000 description 1
- 108010079786 Minichromosome Maintenance Complex Component 4 Proteins 0.000 description 1
- 108091092919 Minisatellite Proteins 0.000 description 1
- 241000713869 Moloney murine leukemia virus Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 101710101143 Myosin light polypeptide 6 Proteins 0.000 description 1
- 101710107065 Myosin regulatory light polypeptide 9 Proteins 0.000 description 1
- 102000005238 NM23 Nucleoside Diphosphate Kinases Human genes 0.000 description 1
- 101710117081 Neutrophil defensin 1 Proteins 0.000 description 1
- 101710117152 Neutrophil defensin 3 Proteins 0.000 description 1
- 102100033174 Neutrophil elastase Human genes 0.000 description 1
- 108010088865 Nicotinamide N-Methyltransferase Proteins 0.000 description 1
- 102000009063 Nicotinamide N-methyltransferase Human genes 0.000 description 1
- 206010029719 Nonspecific reaction Diseases 0.000 description 1
- 241000272458 Numididae Species 0.000 description 1
- 102000004264 Osteopontin Human genes 0.000 description 1
- 108010081689 Osteopontin Proteins 0.000 description 1
- 101000989950 Otolemur crassicaudatus Hemoglobin subunit alpha-A Proteins 0.000 description 1
- 101000666901 Oxyuranus scutellatus scutellatus Kunitz-type serine protease inhibitor taicotoxin Proteins 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 108010077519 Peptide Elongation Factor 2 Proteins 0.000 description 1
- 108010030544 Peptidyl-Lys metalloendopeptidase Proteins 0.000 description 1
- 101710204191 Phosphatidylethanolamine-binding protein 1 Proteins 0.000 description 1
- 102100032543 Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN Human genes 0.000 description 1
- 101710132081 Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN Proteins 0.000 description 1
- 102100036062 Phosphatidylinositol transfer protein alpha isoform Human genes 0.000 description 1
- 101710116324 Phosphatidylinositol transfer protein alpha isoform Proteins 0.000 description 1
- 101710089895 Phosphoenolpyruvate carboxykinase [GTP], mitochondrial Proteins 0.000 description 1
- 102100034792 Phosphoenolpyruvate carboxykinase [GTP], mitochondrial Human genes 0.000 description 1
- 108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 1
- 102400000745 Potential peptide Human genes 0.000 description 1
- 101800001357 Potential peptide Proteins 0.000 description 1
- 102000003946 Prolactin Human genes 0.000 description 1
- 108010057464 Prolactin Proteins 0.000 description 1
- 102100023832 Prolyl endopeptidase FAP Human genes 0.000 description 1
- 101710103857 Proteasome activator complex subunit 3 Proteins 0.000 description 1
- 102000006010 Protein Disulfide-Isomerase Human genes 0.000 description 1
- 102100023095 Protein Niban 3 Human genes 0.000 description 1
- 102100029812 Protein S100-A12 Human genes 0.000 description 1
- 101710110949 Protein S100-A12 Proteins 0.000 description 1
- 102100032442 Protein S100-A8 Human genes 0.000 description 1
- 101710156987 Protein S100-A8 Proteins 0.000 description 1
- 101710156990 Protein S100-A9 Proteins 0.000 description 1
- 101710106306 Protein disulfide-isomerase A6 Proteins 0.000 description 1
- 101710106759 Protein-tyrosine kinase 2-beta Proteins 0.000 description 1
- 108010026552 Proteome Proteins 0.000 description 1
- 102100027384 Proto-oncogene tyrosine-protein kinase Src Human genes 0.000 description 1
- 101710134436 Putative uncharacterized protein Proteins 0.000 description 1
- 108010070648 Pyridoxal Kinase Proteins 0.000 description 1
- 101710113459 RAC-alpha serine/threonine-protein kinase Proteins 0.000 description 1
- 238000010357 RNA editing Methods 0.000 description 1
- 230000026279 RNA modification Effects 0.000 description 1
- 238000003559 RNA-seq method Methods 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- 101710193245 Regenerating islet-derived protein 4 Proteins 0.000 description 1
- 102100026436 Regulator of MON1-CCZ1 complex Human genes 0.000 description 1
- 208000014633 Retinitis punctata albescens Diseases 0.000 description 1
- 102100025642 Rho GDP-dissociation inhibitor 1 Human genes 0.000 description 1
- 101710199528 Rho-related GTP-binding protein RhoB Proteins 0.000 description 1
- 101710199530 Rho-related GTP-binding protein RhoC Proteins 0.000 description 1
- 101710132192 Ribosome-binding protein 1 Proteins 0.000 description 1
- 108050007572 S-phase kinase-associated protein 1 Proteins 0.000 description 1
- 102000005155 SKP1 Human genes 0.000 description 1
- 101000702553 Schistosoma mansoni Antigen Sm21.7 Proteins 0.000 description 1
- 101000714192 Schistosoma mansoni Tegument antigen Proteins 0.000 description 1
- 108010089384 Secretagogins Proteins 0.000 description 1
- 102000007969 Secretagogins Human genes 0.000 description 1
- 101710132826 Selenium-binding protein 1 Proteins 0.000 description 1
- 102000012060 Septin 9 Human genes 0.000 description 1
- 108050002584 Septin 9 Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- 102100037310 Serine/threonine-protein kinase D1 Human genes 0.000 description 1
- 101710125010 Serine/threonine-protein kinase D1 Proteins 0.000 description 1
- 101710181599 Serine/threonine-protein kinase STK11 Proteins 0.000 description 1
- 102100025512 Serpin B6 Human genes 0.000 description 1
- 101710181102 Signal transducer CD24 Proteins 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 101710190370 Splicing factor 3B subunit 3 Proteins 0.000 description 1
- 101710092169 Spondin-2 Proteins 0.000 description 1
- 101000829189 Staphylococcus aureus Glutamyl endopeptidase Proteins 0.000 description 1
- 101710111177 Stress-70 protein, mitochondrial Proteins 0.000 description 1
- 101710153934 Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial Proteins 0.000 description 1
- 102100023155 Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial Human genes 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 108010062276 T-Cell Acute Lymphocytic Leukemia Protein 1 Proteins 0.000 description 1
- 102000011768 T-Cell Acute Lymphocytic Leukemia Protein 1 Human genes 0.000 description 1
- 102100040365 T-cell acute lymphocytic leukemia protein 1 Human genes 0.000 description 1
- 108010077678 Tetraspanin 30 Proteins 0.000 description 1
- 102000010428 Tetraspanin 30 Human genes 0.000 description 1
- 108010022173 Thiosulfate sulfurtransferase Proteins 0.000 description 1
- 102100034707 Thiosulfate sulfurtransferase Human genes 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 102000017340 Tissue alpha-L-fucosidases Human genes 0.000 description 1
- 108050005351 Tissue alpha-L-fucosidases Proteins 0.000 description 1
- 101710120037 Toxin CcdB Proteins 0.000 description 1
- 102000004338 Transferrin Human genes 0.000 description 1
- 108090000901 Transferrin Proteins 0.000 description 1
- 101710124052 Transforming protein RhoA Proteins 0.000 description 1
- 108010043652 Transketolase Proteins 0.000 description 1
- 101710094685 Transmembrane gamma-carboxyglutamic acid protein 4 Proteins 0.000 description 1
- 101710186456 Tropomyosin beta chain Proteins 0.000 description 1
- 101710152431 Trypsin-like protease Proteins 0.000 description 1
- 108010020713 Tth polymerase Proteins 0.000 description 1
- 102000004243 Tubulin Human genes 0.000 description 1
- 108090000704 Tubulin Proteins 0.000 description 1
- 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 1
- 108010078814 Tumor Suppressor Protein p53 Proteins 0.000 description 1
- 102100035284 Tumor necrosis factor receptor superfamily member 6B Human genes 0.000 description 1
- 101710187622 Tumor necrosis factor receptor superfamily member 6B Proteins 0.000 description 1
- 101710169430 Tumor necrosis factor-inducible gene 6 protein Proteins 0.000 description 1
- 108030001662 UDP-glucose 6-dehydrogenases Proteins 0.000 description 1
- 101710159648 Uncharacterized protein Proteins 0.000 description 1
- 102100031358 Urokinase-type plasminogen activator Human genes 0.000 description 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 1
- 241000282840 Vicugna vicugna Species 0.000 description 1
- 102100035071 Vimentin Human genes 0.000 description 1
- 108010065472 Vimentin Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 101000649206 Xanthomonas campestris pv. campestris (strain 8004) Uridine 5'-monophosphate transferase Proteins 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 208000009956 adenocarcinoma Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 108010050122 alpha 1-Antitrypsin Proteins 0.000 description 1
- 229940024142 alpha 1-antitrypsin Drugs 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000004082 amperometric method Methods 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 238000011948 assay development Methods 0.000 description 1
- 238000002820 assay format Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000010504 bond cleavage reaction Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 1
- 238000007816 calorimetric assay Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 102000023852 carbohydrate binding proteins Human genes 0.000 description 1
- 108091008400 carbohydrate binding proteins Proteins 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000006652 catabolic pathway Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000000423 cell based assay Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 150000005829 chemical entities Chemical class 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 238000000546 chi-square test Methods 0.000 description 1
- 210000000991 chicken egg Anatomy 0.000 description 1
- 238000007813 chromatographic assay Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 239000003541 chymotrypsin inhibitor Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 108090001092 clostripain Proteins 0.000 description 1
- 108010022822 collapsin response mediator protein-2 Proteins 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 238000007821 culture assay Methods 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- 238000007822 cytometric assay Methods 0.000 description 1
- 238000013499 data model Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 210000005045 desmin Anatomy 0.000 description 1
- 239000012502 diagnostic product Substances 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000009274 differential gene expression Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 238000007812 electrochemical assay Methods 0.000 description 1
- 238000002848 electrochemical method Methods 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000007823 electrophoretic assay Methods 0.000 description 1
- 238000002101 electrospray ionisation tandem mass spectrometry Methods 0.000 description 1
- 238000000572 ellipsometry Methods 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 229940066758 endopeptidases Drugs 0.000 description 1
- 108010022937 endoplasmin Proteins 0.000 description 1
- 238000007824 enzymatic assay Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 210000001723 extracellular space Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 108010055671 ezrin Proteins 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 108010048325 fibrinopeptides gamma Proteins 0.000 description 1
- 108010072257 fibroblast activation protein alpha Proteins 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000011223 gene expression profiling Methods 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 230000035430 glutathionylation Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 201000005787 hematologic cancer Diseases 0.000 description 1
- 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 description 1
- 238000007825 histological assay Methods 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 238000000126 in silico method Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000005305 interferometry Methods 0.000 description 1
- 229940096397 interleukin-8 Drugs 0.000 description 1
- XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 description 1
- 229940118526 interleukin-9 Drugs 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 1
- 238000000534 ion trap mass spectrometry Methods 0.000 description 1
- 229910052747 lanthanoid Inorganic materials 0.000 description 1
- 150000002602 lanthanoids Chemical class 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 238000001698 laser desorption ionisation Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000007477 logistic regression Methods 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 108010026228 mRNA guanylyltransferase Proteins 0.000 description 1
- 238000010801 machine learning Methods 0.000 description 1
- 238000007885 magnetic separation Methods 0.000 description 1
- 238000013178 mathematical model Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 238000010208 microarray analysis Methods 0.000 description 1
- 238000012775 microarray technology Methods 0.000 description 1
- 238000007814 microscopic assay Methods 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 230000009149 molecular binding Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 108091027963 non-coding RNA Proteins 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 238000007826 nucleic acid assay Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000011369 optimal treatment Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 108010029648 pantetheinase Proteins 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 238000000955 peptide mass fingerprinting Methods 0.000 description 1
- 239000000816 peptidomimetic Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 108030002458 peroxiredoxin Proteins 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 238000010837 poor prognosis Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229940097325 prolactin Drugs 0.000 description 1
- 230000001915 proofreading effect Effects 0.000 description 1
- NQLVQOSNDJXLKG-UHFFFAOYSA-N prosulfocarb Chemical compound CCCN(CCC)C(=O)SCC1=CC=CC=C1 NQLVQOSNDJXLKG-UHFFFAOYSA-N 0.000 description 1
- 108020003519 protein disulfide isomerase Proteins 0.000 description 1
- 108020001580 protein domains Proteins 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 238000007828 protein synthesis assay Methods 0.000 description 1
- 238000000575 proteomic method Methods 0.000 description 1
- 238000005173 quadrupole mass spectroscopy Methods 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000007829 radioisotope assay Methods 0.000 description 1
- 238000007637 random forest analysis Methods 0.000 description 1
- 238000007830 receptor-based assay Methods 0.000 description 1
- 206010038038 rectal cancer Diseases 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 1
- 108010084871 rho Guanine Nucleotide Dissociation Inhibitor alpha Proteins 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000007423 screening assay Methods 0.000 description 1
- 238000001004 secondary ion mass spectrometry Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 108010017282 serpin B6 Proteins 0.000 description 1
- 238000002579 sigmoidoscopy Methods 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 238000002553 single reaction monitoring Methods 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000007811 spectroscopic assay Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000002563 stool test Methods 0.000 description 1
- 238000012799 strong cation exchange Methods 0.000 description 1
- 238000012437 strong cation exchange chromatography Methods 0.000 description 1
- 108010059339 submandibular proteinase A Proteins 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 1
- 238000004885 tandem mass spectrometry Methods 0.000 description 1
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000004797 therapeutic response Effects 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 238000001269 time-of-flight mass spectrometry Methods 0.000 description 1
- 238000007815 topographic assay Methods 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 208000022271 tubular adenoma Diseases 0.000 description 1
- 208000022158 tubulovillous adenoma Diseases 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 102000003298 tumor necrosis factor receptor Human genes 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 108090000195 villin Proteins 0.000 description 1
- 208000009540 villous adenoma Diseases 0.000 description 1
- 210000005048 vimentin Anatomy 0.000 description 1
- 238000004832 voltammetry Methods 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
- G01N2800/7023—(Hyper)proliferation
- G01N2800/7028—Cancer
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Theoretical Computer Science (AREA)
- Evolutionary Biology (AREA)
- Biophysics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Data Mining & Analysis (AREA)
- Genetics & Genomics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Artificial Intelligence (AREA)
- Evolutionary Computation (AREA)
- Public Health (AREA)
- Software Systems (AREA)
- Epidemiology (AREA)
- Databases & Information Systems (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Bioethics (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261732024P | 2012-11-30 | 2012-11-30 | |
| US61/732,024 | 2012-11-30 | ||
| US201361772979P | 2013-03-05 | 2013-03-05 | |
| US61/772,979 | 2013-03-05 | ||
| PCT/US2013/072691 WO2014085826A2 (en) | 2012-11-30 | 2013-12-02 | Method for evaluation of presence of or risk of colon tumors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2013351947A1 true AU2013351947A1 (en) | 2015-06-18 |
Family
ID=50828610
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2013351947A Abandoned AU2013351947A1 (en) | 2012-11-30 | 2013-12-02 | Method for evaluation of presence of or risk of colon tumors |
Country Status (11)
| Country | Link |
|---|---|
| US (6) | US20140234854A1 (enExample) |
| EP (1) | EP2926138A4 (enExample) |
| JP (1) | JP2016507723A (enExample) |
| KR (1) | KR20150090240A (enExample) |
| CN (2) | CN110596385A (enExample) |
| AU (1) | AU2013351947A1 (enExample) |
| BR (1) | BR112015012616A2 (enExample) |
| CA (1) | CA2893158A1 (enExample) |
| MX (1) | MX2015006757A (enExample) |
| SG (1) | SG11201504241QA (enExample) |
| WO (1) | WO2014085826A2 (enExample) |
Families Citing this family (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9141756B1 (en) | 2010-07-20 | 2015-09-22 | University Of Southern California | Multi-scale complex systems transdisciplinary analysis of response to therapy |
| US9726668B2 (en) | 2012-02-09 | 2017-08-08 | Memed Diagnostics Ltd. | Signatures and determinants for diagnosing infections and methods of use thereof |
| AU2015237229A1 (en) * | 2014-03-28 | 2016-11-10 | Applied Proteomics, Inc. | Protein biomarker profiles for detecting colorectal tumors |
| KR20170029531A (ko) * | 2014-07-11 | 2017-03-15 | 익스프레션 패톨로지, 인크. | GTPase KRas 단백질(KRas)에 대한 SRM/MRM 검정 |
| CA3190715A1 (en) | 2014-08-14 | 2016-02-18 | Memed Diagnostics Ltd. | Computational analysis of biological data using manifold and a hyperplane |
| JP2017532699A (ja) * | 2014-09-05 | 2017-11-02 | ナントミクス，エルエルシー | 起源の判定のためのシステムと方法 |
| AU2015360420B2 (en) * | 2014-12-11 | 2021-12-09 | Wisconsin Alumni Research Foundation | Methods for detection and treatment of colorectal cancer |
| CN107209184B (zh) | 2014-12-11 | 2020-04-24 | 米密德诊断学有限公司 | 用于诊断多种感染的标记组合及其使用方法 |
| CN105807062A (zh) * | 2014-12-28 | 2016-07-27 | 复旦大学 | 人结肠癌蛋白Spondin-2在制备结肠癌诊断制剂中的应用 |
| CN105385752A (zh) * | 2015-03-23 | 2016-03-09 | 复旦大学 | 一种人结肠癌蛋白质标志物Spondin-2的检测方法及其检测试剂盒 |
| GB2545361B (en) * | 2015-04-10 | 2018-01-24 | Applied Proteomics Inc | Methods of assessing colorectal cancer status |
| JP7002037B2 (ja) * | 2015-07-01 | 2022-02-04 | デューク・ユニヴァーシティ | 急性呼吸器感染症を診断および処置するための方法 |
| EP3371605B1 (en) * | 2015-11-05 | 2021-06-23 | Vanderbilt University | Protein quantitation in multicellular tissue specimens |
| WO2017149548A1 (en) | 2016-03-03 | 2017-09-08 | Memed Diagnostics Ltd. | Rna determinants for distinguishing between bacterial and viral infections |
| US20190130994A1 (en) * | 2016-04-11 | 2019-05-02 | Discerndx, Inc. | Mass Spectrometric Data Analysis Workflow |
| JP6754116B2 (ja) * | 2016-04-26 | 2020-09-09 | 学校法人近畿大学 | 大腸癌マーカー |
| CN107345236A (zh) * | 2016-05-04 | 2017-11-14 | 北京美泽福临科技发展有限公司 | 一种amy2b信使rna的特异性扩增引物和肝癌辅助诊断试剂盒 |
| WO2017214625A1 (en) * | 2016-06-10 | 2017-12-14 | Wisconsin Alumni Research Foundation | Methods for detection, staging, and surveillance of colorectal adenomas and carcinomas |
| EP4141448A1 (en) | 2016-07-10 | 2023-03-01 | MeMed Diagnostics Ltd. | Protein signatures for distinguishing between bacterial and viral infections |
| EP3482201B1 (en) | 2016-07-10 | 2022-12-14 | Memed Diagnostics Ltd. | Early diagnosis of infections |
| CN106202984B (zh) * | 2016-08-26 | 2018-09-04 | 赵毅 | 一种基于多层复杂网络对肿瘤miRNA标志物的筛选方法 |
| EP3519834A4 (en) * | 2016-09-29 | 2020-06-17 | MeMed Diagnostics Ltd. | RISK ASSESSMENT AND DISEASE CLASSIFICATION METHODS |
| WO2018060998A1 (en) | 2016-09-29 | 2018-04-05 | Memed Diagnostics Ltd. | Methods of prognosis and treatment |
| US20180100858A1 (en) * | 2016-10-07 | 2018-04-12 | Applied Proteomics, Inc. | Protein biomarker panels for detecting colorectal cancer and advanced adenoma |
| JP6813033B2 (ja) * | 2017-01-19 | 2021-01-13 | 株式会社島津製作所 | 分析データ解析方法および分析データ解析装置 |
| US11204355B2 (en) | 2017-02-20 | 2021-12-21 | Vanderbilt University | Immune checkpoint molecular fitness profiling by mass spectrometry |
| CN106919801B (zh) * | 2017-03-08 | 2023-07-18 | 杭州大伽信息科技有限公司 | 一种免疫组织化学染色辅助分析系统及使用方法 |
| CN106908608B (zh) * | 2017-04-17 | 2018-10-02 | 首都医科大学附属北京胸科医院 | 辅助诊断重症继发性肺结核的蛋白标志物 |
| US20180330059A1 (en) * | 2017-05-09 | 2018-11-15 | James Stewart Bates | Patient treatment systems and methods |
| US10455457B2 (en) | 2017-05-24 | 2019-10-22 | Qualcomm Incorporated | NR-SS unified operation mode in coordinated and uncoordinated bands |
| US11164679B2 (en) | 2017-06-20 | 2021-11-02 | Advinow, Inc. | Systems and methods for intelligent patient interface exam station |
| WO2019004430A1 (ja) * | 2017-06-30 | 2019-01-03 | 国立研究開発法人医薬基盤・健康・栄養研究所 | 大腸がんを検出するためのバイオマーカー |
| AU2018301704A1 (en) * | 2017-07-14 | 2020-03-05 | Cofactor Genomics, Inc. | Immuno-oncology applications using next generation sequencing |
| CN109406785A (zh) * | 2017-08-18 | 2019-03-01 | 山东泽济生物科技有限公司 | 肿瘤血液标志物及其应用 |
| US20200386759A1 (en) * | 2017-12-05 | 2020-12-10 | Discerndx, Inc. | Robust panels of colorectal cancer biomarkers |
| WO2019133717A1 (en) * | 2017-12-29 | 2019-07-04 | Abbott Laboratories | Novel biomarkers and methods for diagnosing and evaluating traumatic brain injury |
| ES2917629T3 (es) | 2018-01-22 | 2022-07-11 | Liquid Biopsy Res Llc | Métodos para la detección del cáncer de colon y monitorización del tratamiento |
| US11348688B2 (en) | 2018-03-06 | 2022-05-31 | Advinow, Inc. | Systems and methods for audio medical instrument patient measurements |
| JP7455757B2 (ja) * | 2018-04-13 | 2024-03-26 | フリーノーム・ホールディングス・インコーポレイテッド | 生体試料の多検体アッセイのための機械学習実装 |
| WO2020010256A1 (en) * | 2018-07-05 | 2020-01-09 | Edp Biotech Corporation | Kits and methods for detecting markers |
| SG11202100834SA (en) | 2018-08-08 | 2021-02-25 | Regeneron Pharma | Use of lc-ms/ms to quantitate protein biomarkers |
| EP3623813A1 (en) * | 2018-09-17 | 2020-03-18 | Institut d'Investigació Sanitària Pere Virgili | Methods for the prognosis of hiv-infected subjects |
| WO2020178620A1 (en) * | 2019-03-06 | 2020-09-10 | Diadem S.R.L. | p53 PEPTIDES AS MARKERS IN THE DIAGNOSIS AND PROGNOSIS OF ALZHEIMER'S DISEASE |
| US12499537B2 (en) * | 2019-11-13 | 2025-12-16 | University Of South Florida | Systems and methods of deep learning for colorectal polyp screening |
| CN110951707B (zh) * | 2019-12-31 | 2022-11-11 | 南京医科大学 | 丙酮酸激酶m2突变体及其在心血管疾病中的应用 |
| CN115616230A (zh) * | 2020-03-18 | 2023-01-17 | 龙海市第一医院 | 用于肝癌早期诊断的检测岩藻糖基化载脂蛋白h的elisa试剂盒 |
| WO2022006628A1 (en) * | 2020-07-08 | 2022-01-13 | Southern Adelaide Local Health Network Inc. | Computer-implemented method and system for identifying measurable features for use in a predictive model |
| CN112194719A (zh) * | 2020-09-01 | 2021-01-08 | 中日友好医院(中日友好临床医学研究所) | Crt抗原和mage-a1抗原的制备及其应用 |
| CN112034182A (zh) * | 2020-09-01 | 2020-12-04 | 复旦大学附属中山医院 | 一种结肠癌转移预测方法和系统 |
| CN112266961B (zh) * | 2020-10-29 | 2023-05-12 | 中山大学附属第六医院 | Tsg-6基因在预测结直肠癌转移及预后方面的应用 |
| CN112710856B (zh) * | 2020-12-16 | 2022-12-02 | 江西省肿瘤医院(江西省癌症中心) | 检测血清igf1蛋白的制剂在制备结直肠癌疗效监测试剂中的应用 |
| CN113447658B (zh) * | 2021-07-01 | 2022-04-19 | 浙江大学 | 一种检测抗过氧化物还原酶-1-IgG抗体的试剂盒 |
| CN113956327B (zh) * | 2021-10-11 | 2024-01-30 | 中山大学肿瘤防治中心 | 靶向人apc蛋白的多肽及其在制备药物中的应用 |
| WO2023183481A1 (en) * | 2022-03-23 | 2023-09-28 | Serum Detect, Inc. | Biomarker signatures indicative of early stages of cancer |
| CN114445406B (zh) * | 2022-04-07 | 2022-08-09 | 武汉大学 | 肠镜图像分析方法、装置和医学图像处理设备 |
| TWI796228B (zh) | 2022-05-25 | 2023-03-11 | 臺中榮民總醫院 | 急性腎損傷預測系統及其方法 |
| CN114668836B (zh) * | 2022-05-27 | 2022-08-19 | 暨南大学 | Pdia6在制备治疗脊髓损伤和修复的药物中的应用 |
| CN114958794B (zh) * | 2022-06-14 | 2023-06-02 | 南京工业大学 | 一种苯乙醇胺-N-甲基转移酶hPNMT54及其克隆表达与应用 |
| CN116593431B (zh) * | 2023-04-09 | 2025-11-07 | 湖南科技大学三亚研究院 | 一种基于亲和传感器法的米酵菌酸毒素便携式检测装置及检测方法 |
| WO2024232926A1 (en) * | 2023-05-08 | 2024-11-14 | Venn Biosciences Corporation | Diagnosis of colorectal cancer using targeted quantification of peptides |
| WO2025058445A1 (ko) * | 2023-09-15 | 2025-03-20 | 연세대학교 산학협력단 | 대장암에 대한 정보 제공 방법 |
| CN118067993B (zh) * | 2024-04-17 | 2024-07-05 | 弗雷米德生物医药技术（天津）有限公司 | 一种用于肠息肉检测的联检试剂盒及其制备方法、检测方法和应用 |
| CN118496322A (zh) * | 2024-05-09 | 2024-08-16 | 昆明医科大学 | 一种靶向降解β-catenin的多肽型抑制剂及其应用 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4444879A (en) * | 1981-01-29 | 1984-04-24 | Science Research Center, Inc. | Immunoassay with article having support film and immunological counterpart of analyte |
| US4517289A (en) * | 1982-08-18 | 1985-05-14 | Brigham And Women's Hospital | Monoclonal antibodies for human tissue cross-matching |
| EP0854934A4 (en) * | 1995-08-18 | 2000-09-06 | Donald W Landry | DETECTION OF ORGANIC COMPOUNDS BY REGULATION OF ANTIBODY CATALYZED REACTIONS |
| US5800347A (en) * | 1995-11-03 | 1998-09-01 | The General Hospital Corporation | ROC method for early detection of disease |
| NO954667D0 (no) * | 1995-11-17 | 1995-11-17 | Dagfinn Oegreid | Fremgangsmåte til deteksjon av Ki-ras mutasjoner |
| EP1179092A2 (en) * | 1999-01-10 | 2002-02-13 | Exact Sciences Corporation | Methods of detecting colorectal disease by conduction an assay to detect a mutation in a bat-26 locus |
| US20010041365A1 (en) * | 2000-01-10 | 2001-11-15 | Michael Laposata | Methods for monitoring alcohol consumption |
| US20040018973A1 (en) * | 2002-01-25 | 2004-01-29 | University Of Pittsburgh | Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof |
| US20050153382A1 (en) * | 2002-06-06 | 2005-07-14 | Chengdu Kuachang Science And Technology Co., Ltd. | Biochip kit comprising biochip based on antigen-antibody reactions, and its usage |
| EP2026071B1 (en) * | 2004-02-19 | 2013-07-31 | Yale University | Identification of cancer protein biomarkers using proteomic techniques |
| JP4916441B2 (ja) * | 2004-08-13 | 2012-04-11 | インディヴュームド ゲゼルシャフト ミット ベシュレンクテル ハフツング | 結腸直腸腺腫及び／又は癌腫に対するバイオマーカーとしてのトランスサイレチンの使用；検出方法及び試験システム |
| US20060105419A1 (en) * | 2004-08-16 | 2006-05-18 | Biosite, Inc. | Use of a glutathione peroxidase 1 as a marker in cardiovascular conditions |
| WO2006094149A2 (en) * | 2005-03-01 | 2006-09-08 | Exact Sciences Corporation | Methods and compositions for detecting adenoma |
| CN101283280A (zh) * | 2005-08-18 | 2008-10-08 | Zadec私人有限公司 | 用于诊断结直肠癌的蛋白质标记和所述标记作为所述癌症类型治疗的药物靶点的用途 |
| CA2629013A1 (en) * | 2005-11-10 | 2007-12-13 | Aurelium Biopharma Inc. | Method of diagnosing breast cancer using protein markers |
| JP5715817B2 (ja) * | 2007-07-19 | 2015-05-13 | ビオメリューＢｉｏｍｅｒｉｅｕｘ | 結腸直腸癌のインビトロ診断のための肝臓脂肪酸結合タンパク質、ｃｅａおよびｃａ１９−９のアッセイのための方法 |
| WO2009040782A2 (en) * | 2007-09-28 | 2009-04-02 | Royal College Of Surgeons In Ireland | A method of assessing colorectal cancer status in an individual |
| CA2701970A1 (en) * | 2007-12-10 | 2009-06-18 | F. Hoffmann-La Roche Ag | Marker panel for colorectal cancer |
| ATE524740T1 (de) * | 2007-12-10 | 2011-09-15 | Hoffmann La Roche | Seprase als krebsmarker |
| CN102027128A (zh) * | 2008-02-11 | 2011-04-20 | 哈达斯特医学服务与开发有限公司 | 作为癌症标志物的结肠癌相关的转录物1(ccat-1) |
| US20110076700A1 (en) * | 2008-02-29 | 2011-03-31 | Nihon University | Anti-crp antibody and utilization of the same |
| US20110245087A1 (en) * | 2008-03-18 | 2011-10-06 | Gunter Weiss | Method for optimizing and validating an assay for determining the presence or absence of a medical condition |
| US20110065605A1 (en) * | 2008-05-14 | 2011-03-17 | Eth Zurich | Method for biomarker and drug-target discovery for prostate cancer diagnosis and treatment as well as biomarker assays determined therewith |
| EP2796878A1 (en) * | 2008-05-23 | 2014-10-29 | Biocartis NV | New biomarkers for diagnosis, prediction and/or prognosis of sepsis and uses thereof |
| KR20120105444A (ko) * | 2009-10-15 | 2012-09-25 | 오클라호마 메디컬 리써치 화운데이션 | 염증성 질병의 활성 측정 및 모니터링을 위한 바이오마커 및 방법 |
| US10119959B2 (en) * | 2010-06-25 | 2018-11-06 | The Board Of Trustees Of The Leland Stanford Junior University | Method of assaying an individual for immune impairment |
| ES2545515T3 (es) * | 2011-01-28 | 2015-09-11 | F. Hoffmann-La Roche Ag | Biomarcadores combinatorios para aplicaciones clínicas en la gestión del paciente con cáncer de pulmón |
| AU2012220872A1 (en) * | 2011-02-22 | 2013-09-12 | Caris Life Sciences Switzerland Holdings Gmbh | Circulating biomarkers |
| EP2744919A4 (en) * | 2011-08-19 | 2015-04-08 | Myriad Genetics Inc | GENE SIGNATURES FOR PROGNOSIS OF LUNG CANCER AND SELECTION OF THERAPY |
-
2013
- 2013-12-02 CN CN201910577840.7A patent/CN110596385A/zh active Pending
- 2013-12-02 BR BR112015012616A patent/BR112015012616A2/pt not_active IP Right Cessation
- 2013-12-02 KR KR1020157017551A patent/KR20150090240A/ko not_active Withdrawn
- 2013-12-02 AU AU2013351947A patent/AU2013351947A1/en not_active Abandoned
- 2013-12-02 EP EP13858410.7A patent/EP2926138A4/en not_active Ceased
- 2013-12-02 MX MX2015006757A patent/MX2015006757A/es unknown
- 2013-12-02 US US14/094,594 patent/US20140234854A1/en not_active Abandoned
- 2013-12-02 WO PCT/US2013/072691 patent/WO2014085826A2/en not_active Ceased
- 2013-12-02 CN CN201380071930.XA patent/CN104969071B/zh not_active Expired - Fee Related
- 2013-12-02 SG SG11201504241QA patent/SG11201504241QA/en unknown
- 2013-12-02 JP JP2015545504A patent/JP2016507723A/ja active Pending
- 2013-12-02 CA CA2893158A patent/CA2893158A1/en not_active Abandoned
-
2014
- 2014-10-28 US US14/526,181 patent/US20150111223A1/en not_active Abandoned
- 2014-10-28 US US14/526,265 patent/US20150111230A1/en not_active Abandoned
- 2014-10-28 US US14/526,282 patent/US20150111221A1/en not_active Abandoned
- 2014-10-28 US US14/526,221 patent/US20150111220A1/en not_active Abandoned
-
2017
- 2017-06-14 US US15/622,340 patent/US20170285033A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN104969071A (zh) | 2015-10-07 |
| EP2926138A2 (en) | 2015-10-07 |
| WO2014085826A3 (en) | 2014-10-23 |
| WO2014085826A2 (en) | 2014-06-05 |
| US20150111221A1 (en) | 2015-04-23 |
| US20150111220A1 (en) | 2015-04-23 |
| CA2893158A1 (en) | 2014-06-05 |
| CN110596385A (zh) | 2019-12-20 |
| KR20150090240A (ko) | 2015-08-05 |
| US20150111230A1 (en) | 2015-04-23 |
| CN104969071B (zh) | 2019-09-03 |
| BR112015012616A2 (pt) | 2017-09-12 |
| MX2015006757A (es) | 2015-11-30 |
| US20170285033A1 (en) | 2017-10-05 |
| JP2016507723A (ja) | 2016-03-10 |
| US20140234854A1 (en) | 2014-08-21 |
| EP2926138A4 (en) | 2016-09-14 |
| US20150111223A1 (en) | 2015-04-23 |
| SG11201504241QA (en) | 2015-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20170285033A1 (en) | Method for evaluation of presence of or risk of colon tumors | |
| US9689874B2 (en) | Protein biomarker panels for detecting colorectal cancer and advanced adenoma | |
| JP7584486B2 (ja) | 乾癬性関節炎の疾患活動性を評価するためのバイオマーカーおよび方法 | |
| US20170176441A1 (en) | Protein biomarker profiles for detecting colorectal tumors | |
| JP2017148046A (ja) | 照合性細胞ベースのアッセイ及びその使用 | |
| WO2008064336A9 (en) | Autoimmune disease biomarkers | |
| US20180100858A1 (en) | Protein biomarker panels for detecting colorectal cancer and advanced adenoma | |
| HK1248316A1 (en) | Methods of assessing colorectal health of an individual | |
| US20240393337A1 (en) | Lung Cancer Prediction and Uses Thereof | |
| US20240393336A1 (en) | Biomarkers for colorectal cancer | |
| US20230048910A1 (en) | Methods of Determining Impaired Glucose Tolerance | |
| KR20230085151A (ko) | 심혈관 사건 위험 예측 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |